Subject: FDA- MedWatch- Aprotinin Injection (marketed as Trasylol)

Subject: FDA- MedWatch- Aprotinin Injection (marketed as Trasylol)- Patient Enrollment In The Aprotinin Treatment Group Arm of BART Study Stopped MedWatch – The FDA Safety Information and Adverse Event Reporting Program FDA informed healthcare professionals of the Data Safety Monitoring Board's recommendation to stop patient enrollment in the aprotinin treatment group arm of the Blood […]

Merck Recalls 3 Lots Of Invanz

FDA – MedWatch – Merck Recalls 3 Lots Of Invanz (ertapenem sodium) Injection Because The Product May Contain Broken Glass Pieces In The Reconstituted Solution For Injection

FDA ALERT

February 7, 2007Subject: FDA MedWatch: Use of Skin Products Containing Numbing Ingredients (Topical Anesthetic Drugs) for Cosmetic Procedures and Potential Life-Threatening Side EffectsMedWatch – The FDA Safety Information and Adverse Event Reporting ProgramFDA informed consumers and healthcare professionals of the potential hazards of using skin numbing products containing topical anesthetic drugs such as lidocaine, tetracaine, […]